D-Methionine and cisplatin ototoxicity in the guinea pig: D-methionine influences cisplatin pharmacokinetics

Hearing Research

Volumn 165, Issue 1-2, 2002, Pages 53-61

  Ekborn, Andreas ^a   Laurell, Göran ^a   Johnström, Peter ^a   Wallin, Inger ^a   Eksborg, Staffan ^a   Ehrsson, Hans ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cisplatin; D Methionine; Nephrotoxicity; Ototoxicity; Pharmacokinetics; Positron emission tomography

Indexed keywords

CISPLATIN; CISPLATIN DERIVATIVE; CREATININE; METHIONINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; AUDITORY THRESHOLD; CELL COUNT; CELL LOSS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOSE RESPONSE; DRUG DISTRIBUTION; DRUG EFFECT; ELECTROPHYSIOLOGY; EVOKED BRAIN STEM AUDITORY RESPONSE; GUINEA PIG; HAIR CELL; NEPHROTOXICITY; NONHUMAN; OTOTOXICITY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVERSED PHASE LIQUID CHROMATOGRAPHY; ULTRAFILTRATION;

ANIMALS; ANTINEOPLASTIC AGENTS; BODY WEIGHT; CISPLATIN; CREATINE; CYTOPROTECTION; EAR; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; FEMALE; GUINEA PIGS; KIDNEY; MALE; METHIONINE; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0036100452     PISSN: 03785955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5955(02)00277-0     Document Type: Article

References (33)

1. Some procedures to reduce cis-platinum toxicity reduce antitumour activity
2. Exacerbation of cisplatin induced nephrotoxicity by methionine
3. Determination of cisplatin and cis-diammineaquachloroplatinum(II) ion by liquid chromatography using post-column derivatization with diethyldithiocarbamate
4. Pharmacokinetics of cisplatin and its monohydrated complex in humans
5. Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: Clinical correlation for cisplatin resistance of ovarian carcinoma
6. Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer
7. Statistical estimations in pharmacokinetics
8. Partial reversibility of cisplatin nephrotoxicity in children
9. D-methionine provides excellent protection from cisplatin ototoxicity in the rat
10. Morphological and functional preservation of the outer hair cells from noise trauma by sound conditioning
11. 11C]methionine: Effects of transamination and transmethylation
12. Evaluation of D-methionine as a cytoprotectant in cisplatin treatment of an animal model for ovarian cancer
13. Cisplatin: The future
14. Cisplatin metabolites in plasma, a study of their pharmacokinetics and importance in the nephrotoxic and antitumour activity of cisplatin
15. Cisplatin-induced hearing loss: Influence of the mode of drug administration in the guinea pig
16. Cisplatin nephrotoxicity: A summary of preventative interventions
17. Pharmacokinetic and toxicity evaluation of five-day continuous infusion versus intermittent bolus cis-diamminedichloroplatinum(II) in head and neck cancer patients
18. Advanced ovarian cancer: Long-term results of treatment with intensive cisplatin-based chemotherapy of brief duration
19. Kinetic studies of the reactivity between cisplatin and its monoaquo species with L-methionine
20. Rapid feasibility studies of tracers for positron emission tomography: High-resolution PET in small animals with kinetic analysis
21. Synthesis of C-11-labeled D- and L-methionine for positron emission tomography. Investigation of the enantiomeric purity of the products
22. 2+, and the hydrolysis product of cisplatin in the rat
23. Antitumor, nephrotoxic and clastogenic effect of cis-DDP with DDTC or NAC
24. Pharmacokinetics of clonidine after rectal administration in children
25. Testicular cancer and the legacy of chemotherapy
26. Cisplatin dose intensity
27. Ototoxicity in patients receiving cisplatin: Importance of dose and method of drug administration
28. L- and D-methionine provide equivalent long term protection against CDDP-induced ototoxicity in vivo, with partial in vitro and in vivo retention of antineoplastic activity
29. Mechanism of protection by diethyldithiocarbamate against cisplatin ototoxicity: Antioxidant system
30. Cisplatin dose rate as a risk factor for nephrotoxicity in children
31. Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies
32. Ototoxicity of cis-diamminedichloroplatinum(II): Influence of dose, schedule and mode of administration
33. The kinetics and cytotoxicity of cisplatin and its monohydrated complex